Health news
Phase 3 Results of KEYNOTE-775/Study 309 Trial KEYTRUDA Plus LENVIMA in Advanced Endometrial Carcinoma Published in New England Journal of Medicine
Oh No! Illegal Sex Activity Still Continues Behind Men’s Toilet located in DC Office Campus. It is indeed shameful, that too inside a DC Office premises,
Learn about abdominal desmoid tumors, including symptoms, risk factors, treatment, and outlook.
Hypothyroidism with normal TSH can indicate subclinical hypothyroidism or a less common form of the condition that health experts call central hypothyroidism.
For transgender people, starting gender-affirming hormone treatment in adolescence is linked to better mental health than waiting until adulthood, according to new research led by the Stanford University School of Medicine.
Hypoglycemia and anemia are not related conditions, but they can share similar symptoms and some of the same root causes. Learn more here.
MANHASSET, N.Y.–(BUSINESS WIRE)–Jan 18, 2022–
Exelixis, Inc. (Nasdaq: EXEL) today announced results for cabozantinib (CABOMETYX®) in combination with immunotherapies in patients with advanced colo
Positive results from the TOPAZ-1 Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care chemotherapy, demons
KEYTRUDA Significantly Improved Overall Survival (OS) in Patients With Advanced Hepatocellular Carcinoma (HCC) Previously Treated With Sorafenib
